Chemical Formula: C21H23NO3

Chemical Formula C21H23NO3

Found 23 metabolite its formula value is C21H23NO3

Olopatadine

2-[(2Z)-2-[3-(dimethylamino)propylidene]-9-oxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-5-yl]acetic acid

C21H23NO3 (337.16778480000005)


Used to treat allergic conjunctivitis (itching eyes), olopatadine inhibits the release of histamine from mast cells. It is a relatively selective histamine H1 antagonist that inhibits the in vivo and in vitro type 1 immediate hypersensitivity reaction including inhibition of histamine induced effects on human conjunctival epithelial cells. R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents D018926 - Anti-Allergic Agents

   

3-Quinuclidinyl benzilate

1-azabicyclo[2.2.2]octan-3-yl 2-hydroxy-2,2-diphenylacetate

C21H23NO3 (337.16778480000005)


D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists

   

3-(4-t-Butylphenyl)-N-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide

3-(4-tert-butylphenyl)-N-(2,3-dihydro-1,4-benzodioxin-6-yl)prop-2-enamide

C21H23NO3 (337.16778480000005)


   

2-[11-[3-(Dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid

2-{2-[3-(dimethylamino)propylidene]-9-oxatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3(8),4,6,11,13-hexaen-5-yl}acetic acid

C21H23NO3 (337.16778480000005)


   

N-(p-Amylcinnamoyl)anthranilic acid

2-[3-(4-pentylphenyl)prop-2-enamido]benzoic acid

C21H23NO3 (337.16778480000005)


   

Pargeverine

2-(Dimethylamino)ethyl 2,2-diphenyl-2-(prop-2-yn-1-yloxy)acetic acid

C21H23NO3 (337.16778480000005)


   

1-Azabicyclo[2.2.2]octan-2-yl 2-hydroxy-2,2-diphenylacetate

1-Azabicyclo[2.2.2]octan-2-yl 2-hydroxy-2,2-diphenylacetic acid

C21H23NO3 (337.16778480000005)


   
   
   
   

RCS-4 N-(4-hydroxypentyl) metabolite

RCS-4 N-(4-hydroxypentyl) metabolite

C21H23NO3 (337.16778480000005)


   

RCS-4 N-(5-hydroxypentyl) metabolite

RCS-4 N-(5-hydroxypentyl) metabolite

C21H23NO3 (337.16778480000005)


   

Olopatadine

Olopatadine

C21H23NO3 (337.16778480000005)


R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents D018926 - Anti-Allergic Agents CONFIDENCE standard compound; INTERNAL_ID 2210 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3323

   

1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(3-phenylpyrrolidin-1-yl)propan-1-one

1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(3-phenylpyrrolidin-1-yl)propan-1-one

C21H23NO3 (337.16778480000005)


   

(4R,4aS,7aS,12bS)-3-(cyclopropylmethyl)-7-methylene-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol

(4R,4aS,7aS,12bS)-3-(cyclopropylmethyl)-7-methylene-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol

C21H23NO3 (337.16778480000005)


   

4-[(4-METHOXYBENZYLIDENE)AMINO]CINNAMIC ACID N-BUTYL ESTER

4-[(4-METHOXYBENZYLIDENE)AMINO]CINNAMIC ACID N-BUTYL ESTER

C21H23NO3 (337.16778480000005)


   
   

Pargeverine

2-(dimethylamino)ethyl 2,2-diphenyl-2-prop-2-ynoxyacetate

C21H23NO3 (337.16778480000005)


D000890 - Anti-Infective Agents > D000892 - Anti-Infective Agents, Urinary > D008333 - Mandelic Acids C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent

   
   

AMG 9810

(2E)-N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-3-[4-(1,1-dimethylethyl)phenyl]-2-propenamide

C21H23NO3 (337.16778480000005)


   

N-(p-Amylcinnamoyl)anthranilic acid

N-(p-Amylcinnamoyl)anthranilic acid

C21H23NO3 (337.16778480000005)


N-(p-amylcinnamoyl) Anthranilic Acid (ACA) is a broad spectrum Phospholipase A2 (PLA2) inhibitor and TRP channel blocker[1][2]. N-(p-amylcinnamoyl) Anthranilic Acid (ACA) is also an effective reversible inhibitor of calcium-activated chloride channels, has potential to treat arrhythmia[3].

   

2-Piperidinone, 1-[1-oxo-3-[4-(phenylmethoxy)phenyl]propyl]-

2-Piperidinone, 1-[1-oxo-3-[4-(phenylmethoxy)phenyl]propyl]-

C21H23NO3 (337.16778480000005)